GUGGENHEIM CAPITAL LLC - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 56 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2018$18,0000.0%50,201
+0.6%
0.00%
Q4 2017$18,000
-21.7%
49,895
-11.1%
0.00%
Q3 2017$23,000
-14.8%
56,126
+5.2%
0.00%
Q2 2017$27,000
-12.9%
53,3450.0%0.00%
Q1 2017$31,0000.0%53,345
+6.8%
0.00%
Q4 2016$31,000
-32.6%
49,9270.0%0.00%
Q3 2016$46,000
+130.0%
49,927
+235.1%
0.00%
Q4 2015$20,000
-35.5%
14,901
+9.1%
0.00%
Q3 2015$31,0000.0%13,662
-29.6%
0.00%
Q2 2015$31,000
+10.7%
19,401
+8.9%
0.00%
Q1 2015$28,000
-12.5%
17,808
+4.6%
0.00%
Q4 2014$32,000
+60.0%
17,028
+9.7%
0.00%
Q3 2014$20,000
-16.7%
15,518
-5.7%
0.00%
Q2 2014$24,0000.0%16,454
+25.7%
0.00%
Q1 2014$24,000
-20.0%
13,094
-9.9%
0.00%
Q4 2013$30,0000.0%14,528
+30.0%
0.00%
Q2 2013$30,00011,1720.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q3 2017
NameSharesValueWeighting ↓
Sowell Financial Services LLC 506,634$190,0000.05%
Harel Insurance Investments & Financial Services Ltd. 780,000$328,0000.02%
LifePlan Financial Group, Inc 28,810$12,0000.01%
AURORA FINANCIAL ADVISORS, LLC 32,500$11,0000.01%
WEDBUSH SECURITIES INC 169,000$61,0000.01%
Greenwich Wealth Management LLC 60,066$22,0000.00%
Jacobi Capital Management LLC 20,130$8,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 649,880$233,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 436,272$156,0000.00%
McCollum Christoferson Group LLC 17,155$6,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders